- Home
- PTC vs WAT Comparison
PTC vs WAT Comparison
Compare PTC & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTC
- WAT
- Stock Information
- Founded
- PTC 1985
- WAT 1958
- Country
- PTC United States
- WAT United States
- Employees
- PTC N/A
- WAT N/A
- Industry
- PTC Computer Software: Prepackaged Software
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- PTC Technology
- WAT Industrials
- Exchange
- PTC Nasdaq
- WAT Nasdaq
- Market Cap
- PTC 17.3B
- WAT 20.1B
- IPO Year
- PTC 1989
- WAT 1995
- Fundamental
- Price
- PTC $163.02
- WAT $344.39
- Analyst Decision
- PTC Buy
- WAT Buy
- Analyst Count
- PTC 14
- WAT 15
- Target Price
- PTC $191.21
- WAT $387.60
- AVG Volume (30 Days)
- PTC 872.7K
- WAT 489.8K
- Earning Date
- PTC 04-30-2025
- WAT 05-06-2025
- Dividend Yield
- PTC N/A
- WAT N/A
- EPS Growth
- PTC 52.11
- WAT 8.23
- EPS
- PTC 3.64
- WAT 11.02
- Revenue
- PTC $2,346,680,000.00
- WAT $2,983,253,000.00
- Revenue This Year
- PTC $9.20
- WAT $5.16
- Revenue Next Year
- PTC $10.24
- WAT $6.59
- P/E Ratio
- PTC $44.91
- WAT $31.38
- Revenue Growth
- PTC 4.66
- WAT 2.57
- 52 Week Low
- PTC $133.38
- WAT $279.24
- 52 Week High
- PTC $203.09
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- PTC 61.47
- WAT 54.04
- Support Level
- PTC $158.14
- WAT $328.79
- Resistance Level
- PTC $162.95
- WAT $358.29
- Average True Range (ATR)
- PTC 4.73
- WAT 11.77
- MACD
- PTC 1.90
- WAT 3.12
- Stochastic Oscillator
- PTC 81.58
- WAT 83.65
About PTC PTC Inc.
PTC offers high-end computer-assisted design (Creo) and product lifecycle management (Windchill) software as well as Internet of Things and AR industrial solutions. Founded in 1985, PTC has 28,000 customers, with revenue stemming mostly from North America and Europe.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.